Related Experiment Video

Updated: Aug 18, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with

Rocío Sotillo1, Oliver Renner, Pierre Dubus

  • 1Molecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.

Cancer Research
|May 4, 2005
PubMed

Insights

Altered cell cycle regulation drives cancer. This study shows Cdk4 mutations cooperating with p27Kip1 deficiency promote pituitary tumors in mice, which respond to cell cycle inhibitors like flavopiridol.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Cell cycle deregulation, particularly the G1-S transition, is a hallmark of human cancers.
  • Alterations in cyclin-dependent kinases (Cdk), their regulators (cyclins, INK4 inhibitors, p27Kip1), and substrates (retinoblastoma protein) are common in tumors.
  • Cooperation between mutations in different cell cycle components can drive tumor development.

Purpose of the Study:

  • To investigate the cooperative effects of Cdk4 mutations and alterations in cell cycle regulators on tumor development.
  • To evaluate the therapeutic potential of cell cycle inhibitors using a novel genetically engineered mouse model.

Main Methods:

  • Generation and characterization of gene-targeted mouse models, including Cdk4(R/R) knock-in mice and mice with p27Kip1 deficiency.
  • Analysis of tumor development, latency, and penetrance in different genetic backgrounds.
  • Assessment of the therapeutic efficacy of flavopiridol, a broad-spectrum Cdk inhibitor, on tumor progression and survival.

Main Results:

  • Cdk4 resistance to INK4 inhibitors (Cdk4 R24C mutation) strongly cooperates with p27Kip1 deficiency in promoting pituitary tumor development.
  • No cooperation was observed between Cdk4 R24C and p18INK4c absence, suggesting p18INK4c's primary role is Cdk4 inhibition.
  • Cdk4(R/R) mice on a p27Kip1-/- or p27Kip1+/- background developed pituitary tumors with high penetrance and short latency.
  • Flavopiridol treatment significantly delayed tumor progression and improved survival in treated mice.

Conclusions:

  • Genetically engineered mouse models involving key cell cycle regulators are valuable tools for studying cancer development.
  • These models can effectively assess the therapeutic potential of novel anti-cancer drugs, such as cell cycle inhibitors.
  • The findings highlight the complex interplay of cell cycle regulators in tumorigenesis and provide a platform for drug discovery.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...